Prevention of acquired invasive fungal infection with decontamination regimen in mechanically ventilated ICU patients: a pre/post observational study

References

• Taccone FS, Van den Abeele AM, Bulpa P, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care. 2015;19(1):7.
   PubMedGoogle Scholar
• Loughlin L, Hellyer TP, White PL, et al. Pulmonary Aspergillosis in patients with suspected ventilator-associated pneumonia in UK ICUs. Am J Respir Crit Care Med. 2020;202(8):1125–1132.
   PubMed Web of Science ®Google Scholar
• Paiva JA, Pereira JM, Tabah A, et al. Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study. Crit Care. 2016;20:53.
   PubMed Web of Science ®Google Scholar
• Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782–792.
   PubMed Web of Science ®Google Scholar
• Gangneux JP, Dannaoui E, Fekkar A, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med. 2022;10(2):180–190.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Seidel D, Sprute R, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022;7(8):1127–1140.
   PubMed Web of Science ®Google Scholar
• Wittekamp BHJ, Oostdijk EAN, Cuthbertson BH, et al. Selective decontamination of the digestive tract (SDD) in critically ill patients: a narrative review. Intensive Care Med. 2020;46(2):343–349.
   PubMed Web of Science ®Google Scholar
• Massart N, Reizine F, Fillatre P, et al. Multiple-site decontamination regimen decreases acquired infection incidence in mechanically ventilated COVID-19 patients. Ann Intensive Care. 2022;12(1):84.
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):e61–e111.
   PubMed Web of Science ®Google Scholar
• Blot SI, Taccone FS, Van den Abeele AM, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):56–64. 1 Epub 2012 Apr 19. Erratum in: am J Respir Crit Care Med. 2012;186(8):808.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Rijnders BJA, Brüggemann RJM, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46(8):1524–1535.
   PubMed Web of Science ®Google Scholar
• Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):e149–e162.
   PubMed Web of Science ®Google Scholar
• Vacheron CH, Lepape A, Savey A, et al. Attributable mortality of ventilator-associated pneumonia among patients with COVID-19. Am J Respir Crit Care Med. 2022;206(2):161–169.
   PubMed Web of Science ®Google Scholar
• Reizine F, Pinceaux K, Lederlin M, et al. Influenza- and COVID-19-associated pulmonary aspergillosis: are the pictures different? J Fungi. 2021;157(5):388.
   Google Scholar
• van Till JO, van Ruler O, Lamme B, et al. Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review. Crit Care. 2007;11(6):R126.
   PubMed Web of Science ®Google Scholar
• Silvestri L, van Saene HK, Milanese M, et al. Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials. Intensive Care Med. 2005;31(7):898–910.
   PubMed Web of Science ®Google Scholar
• Danion F, Duval C, Séverac F, et al. Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study. Clin Microbiol Infect. 2021;27(11):1644–1651. Epub 2021 Mar 2. PMID: 33662543.
   PubMed Web of Science ®Google Scholar
• Vanderbeke L, Janssen NAF, Bergmans DCJJ, et al. Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial. Intensive Care Med. 2021;47(6):674–686.
   PubMed Web of Science ®Google Scholar
• Hatzl S, Reisinger AC, Posch F, et al. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study. Crit Care. 2021;25(1):335.
   PubMed Web of Science ®Google Scholar
• Van Ackerbroeck S, Rutsaert L, Roelant E, et al. Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis. Crit Care. 2021; 25(1):298.
   PubMed Web of Science ®Google Scholar
• Melchers M, van Zanten ARH, Heusinkveld M, et al. Nebulized Amphotericin B in mechanically ventilated COVID-19 patients to prevent invasive pulmonary aspergillosis: a retrospective cohort study. Crit Care Explor. 2022;4(5):e0696.
   PubMedGoogle Scholar
• Martin-Loeches I, Antonelli M, Cuenca-Estrella M, et al. ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019;45(6):789–805.
   PubMed Web of Science ®Google Scholar
• Buil JB, Schouten JA, Wauters J, et al. Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination. Intensive Care Med. 2022; 48(5):611–612.
   PubMed Web of Science ®Google Scholar
• Panackal AA, Li H, Kontoyiannis DP, et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2010;50(12):1588–1597.
   PubMed Web of Science ®Google Scholar
• Hurley JC. ICU-acquired candidemia within selective digestive decontamination studies: a meta-analysis. Intensive Care Med. 2015;41(11):1877–1885.
   PubMed Web of Science ®Google Scholar
• Nicholas RO, Berry V, Hunter PA, et al. The antifungal activity of mupirocin. J Antimicrob Chemother. 1999;43(4):579–582.
   PubMed Web of Science ®Google Scholar
• Ellepola AN, Samaranayake LP. Adjunctive use of chlorhexidine in oral candidoses: a review. Oral Dis. 2001;7(1):11–17.
   PubMed Web of Science ®Google Scholar